Health Technology
Swiss companies engaged in health technology sector
These Swiss companies operate in the same sector, health technology. Each includes key stats like stock price, daily change, and trading volume to help you make more informed trading decisions. Whether you're tracking industry giants such as Eli Lilly and Company or looking at high-volume movers like Novartis AG, this list offers valuable insights for any trading strategy. Filter and compare companies and stay on top of market trends easily.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|
 LLYEli Lilly and Company | 920.22 B CHF | 950 CHF | +0.53% | 1 | 0.04 | 42.79 | 22.20 CHF | +107.77% | 0.54% | Buy |
| LLYEli Lilly and Company | 920.22 B CHF | 945.303 CHF | +1.68% | 1 | 0.06 | 42.58 | 22.20 CHF | +107.77% | 0.54% | Buy |
 JNJJohnson & Johnson | 518.6 B CHF | 207.537 CHF | +1.34% | 2 | 0.10 | 29.76 | 6.97 CHF | −5.99% | 1.99% | Buy |
| JNJ.USDJohnson & Johnson | 518.6 B CHF | 243.06 USD | 0.00% | 210 | 0.20 | 28.17 | 6.97 CHF | −7.72% | 1.99% | Buy |
 RORoche Holding Ltd | 283.05 B CHF | 360.0 CHF | +1.29% | 25.36 K | 1.29 | 23.49 | 15.33 CHF | +30.49% | 3.00% | Buy |
| ROPRoche Holding Ltd | 283.05 B CHF | 356.388 CHF | +1.73% | 510 | 0.92 | 23.25 | 15.33 CHF | +30.49% | 2.76% | Buy |
| ROPRoche Holding Ltd | 283.05 B CHF | 355.1 CHF | +1.60% | 1.14 M | 1.40 | 23.17 | 15.33 CHF | +30.49% | 2.76% | Buy |
| RHORoche Holding Ltd | 283.05 B CHF | 346.754 CHF | +2.09% | 78 | 2.34 | 22.62 | 15.33 CHF | +30.49% | 3.00% | Buy |
 6MKMerck & Co., Inc. | 264.48 B CHF | 106.470 CHF | +2.52% | 155 | 4.55 | 37.49 | 2.84 CHF | −53.30% | 2.56% | Buy |
| MRK.USDMerck & Co., Inc. | 264.48 B CHF | 126.24 USD | 0.00% | 13.83 K | 8.13 | 35.53 | 2.84 CHF | −48.27% | 2.56% | Buy |
 NOVNNovartis AG | 231.67 B CHF | 126.90 CHF | −0.60% | 1.86 M | 0.77 | 24.14 | 5.26 CHF | −11.50% | 2.92% | Neutral |
| NOVNEENovartis AG TEMP | 231.67 B CHF | 127.20 CHF | +0.08% | 130 K | 1.00 | 24.20 | 5.26 CHF | −11.50% | 2.92% | No rating |
| NOTNovartis AG | 231.67 B CHF | 126.635 CHF | −0.61% | 34 | 0.04 | 24.09 | 5.26 CHF | −11.50% | 2.92% | Neutral |
 ZEGAstraZeneca PLC | 213.74 B CHF | 137.552 CHF | +2.63% | 5 | 0.04 | 26.23 | 5.24 CHF | +17.15% | 1.86% | Buy |
 NOVNovo Nordisk A/S Class B | 176.25 B CHF | 39.575 CHF | −0.49% | 32 | 0.05 | 11.71 | 3.38 CHF | +12.37% | 3.65% | Buy |
 TN8Thermo Fisher Scientific Inc. | 172.53 B CHF | 469.190 CHF | −0.79% | 1 | 0.22 | 31.22 | 15.03 CHF | +9.63% | 0.32% | Buy |
 AMGAmgen Inc. | 165.81 B CHF | 297.069 CHF | +1.73% | 1 | 0.48 | 25.85 | 11.49 CHF | +18.50% | 2.61% | Buy |
 ABLAbbott Laboratories | 146.66 B CHF | 82.476 CHF | +1.54% | 2 | 0.02 | 32.98 | 2.50 CHF | −60.58% | 2.37% | Buy |
 PFEPfizer Inc. | 114.27 B CHF | 19.876 CHF | −0.52% | 50 | 0.08 | 19.07 | 1.04 CHF | −14.58% | 7.01% | Neutral |
| PFEPfizer Inc. | 114.27 B CHF | 20.122 CHF | −1.13% | 36 | 0.12 | 19.30 | 1.04 CHF | −14.58% | 7.01% | Neutral |
 DAPDanaher Corporation | 109.99 B CHF | 138.705 CHF | −0.89% | 92 | 2.09 | 30.47 | 4.55 CHF | +21.88% | 0.75% | Strong buy |
 BRMBristol-Myers Squibb Company | 103.59 B CHF | 48.564 CHF | +9.23% | 110 | 1.01 | 17.06 | 2.85 CHF | +20.75% | 4.03% | Buy |
| BMY.USDBristol-Myers Squibb Company | 103.59 B CHF | 46.200 USD | 0.00% | 225 | 0.00 | 12.97 | 2.85 CHF | +33.76% | 4.03% | Buy |
 SYKStryker Corporation | 103.44 B CHF | 259.932 CHF | −3.69% | 2 | 0.08 | 37.67 | 6.90 CHF | +5.18% | 1.05% | Buy |
 IUI1Intuitive Surgical, Inc. | 97.41 B CHF | 273.366 CHF | +1.08% | 1 | 0.06 | 38.76 | 7.05 CHF | +24.05% | 0.00% | Buy |
 2M6Medtronic Plc | 87.02 B CHF | 64.873 CHF | +0.25% | 62 | 0.19 | 22.27 | 2.91 CHF | −2.72% | 3.43% | Buy |
 SNWSanofi SA | 85.21 B CHF | 72.075 CHF | +1.73% | 1.5 K | 2.07 | 18.19 | 3.96 CHF | −4.80% | 5.42% | Buy |
 GS71GSK plc | 83.63 B CHF | 20.678 CHF | −3.52% | 3 | 0.07 | 13.75 | 1.50 CHF | +72.47% | 3.49% | Neutral |
 ESLEssilorLuxottica SA | 70.36 B CHF | 150.171 CHF | −2.05% | 535 | 2.58 | 32.37 | 4.64 CHF | −3.79% | 2.45% | Strong buy |
 MRKMerck KGaA | 56.23 B CHF | 125.429 CHF | −6.36% | 100 | 0.84 | 23.33 | 5.38 CHF | −13.37% | 1.58% | Buy |
 RGORegeneron Pharmaceuticals, Inc. | 56.19 B CHF | 535.533 CHF | −1.48% | 70 | 9.09 | 16.33 | 32.80 CHF | −5.68% | 0.55% | Buy |
 BSXBoston Scientific Corporation | 53.73 B CHF | 35.651 CHF | +3.22% | 300 | 1.26 | 18.71 | 1.91 CHF | +57.75% | 0.00% | Strong buy |
 UNCUCB S.A. | 43.44 B CHF | 218.279 CHF | −13.42% | 10 | 0.09 | 29.22 | 7.47 CHF | +45.15% | 0.41% | Buy |
 BAYNBayer AG | 42.05 B CHF | 44.18 CHF | −6.71% | 5 | 0.03 | — | −2.03 CHF | +36.10% | 0.24% | Buy |
| BAYNBayer AG | 42.05 B CHF | 42.740 CHF | −1.22% | 73 | 0.22 | — | −2.03 CHF | +36.10% | 0.24% | Buy |
 GALDGalderma Group AG | 40.78 B CHF | 173.65 CHF | +2.57% | 395.08 K | 1.10 | 59.80 | 2.90 CHF | +110.71% | 0.20% | Buy |
| GALDGalderma Group AG | 40.78 B CHF | 172.715 CHF | −0.23% | 199 | 0.83 | 59.47 | 2.90 CHF | +110.71% | 0.20% | Buy |
 LO3Lonza Group AG | 37.35 B CHF | 548.360 CHF | +1.21% | 42 | 0.27 | — | −1.55 CHF | −115.18% | 0.91% | Buy |
| LONNLonza Group AG | 37.35 B CHF | 548.0 CHF | +1.07% | 114.52 K | 0.69 | — | −1.55 CHF | −115.18% | 0.91% | Buy |
 SHLSiemens Healthineers AG | 36.36 B CHF | 31.779 CHF | +0.46% | 24 | 0.38 | 18.44 | 1.72 CHF | −3.15% | 2.85% | Buy |
| SHLSiemens Healthineers AG | 36.36 B CHF | 32.00 CHF | −0.09% | 11 | 0.01 | 18.57 | 1.72 CHF | −3.15% | 2.85% | Buy |
 RVMDRevolution Medicines, Inc. | 32.87 B CHF | 150.183 CHF | −1.31% | 50 | — | — | −5.65 CHF | −59.73% | 0.00% | Strong buy |
 TEVTeva Pharmaceutical Industries Limited Sponsored ADRDR | 29.65 B CHF | 24.526 CHF | −11.91% | 200 | 0.19 | 22.80 | 1.08 CHF | — | 0.00% | Strong buy |
 QTSIQVIA Holdings Inc | 28.37 B CHF | 160.066 CHF | +24.87% | 18 | — | 24.83 | 6.45 CHF | −0.74% | 0.00% | Buy |
 D8YSandoz Group Ltd | 27.99 B CHF | 64.109 CHF | −0.85% | 674 | 0.57 | 37.11 | 1.73 CHF | +35,889.58% | 1.26% | Buy |
| SDZSandoz Group Ltd | 27.99 B CHF | 63.62 CHF | −1.39% | 619.97 K | 0.75 | 36.83 | 1.73 CHF | +35,889.58% | 1.26% | Buy |
 ALCEAlcon AG TEMP | 27.85 B CHF | 55.68 CHF | +1.35% | 103 K | 0.82 | 41.89 | 1.33 CHF | −33.40% | 0.50% | No rating |
| 2U3Alcon AG | 27.85 B CHF | 55.342 CHF | +2.15% | 228 | 0.24 | 41.64 | 1.33 CHF | −33.40% | 0.50% | Strong buy |
| ALCAlcon AG | 27.85 B CHF | 55.74 CHF | +1.90% | 845.37 K | 0.65 | 41.94 | 1.33 CHF | −33.40% | 0.50% | Strong buy |
 ZOEZoetis, Inc. Class A | 25.81 B CHF | 61.582 CHF | +0.31% | 290 | 6.30 | 12.77 | 4.82 CHF | −2.14% | 2.73% | Buy |
| ZTS.USDZoetis, Inc. Class A | 25.81 B CHF | 126.21 USD | 0.00% | 500 | 0.26 | 20.91 | 4.82 CHF | +8.39% | 2.73% | Buy |
 RMEResMed Inc. | 23.14 B CHF | 159.000 CHF | −23.35% | 30 | 3.95 | 19.18 | 8.29 CHF | +5.15% | 1.23% | Buy |
 DC4DexCom, Inc. | 22.55 B CHF | 58.607 CHF | +4.31% | 10 | 0.06 | 31.36 | 1.87 CHF | +58.46% | 0.00% | Strong buy |
 L0TGE Healthcare Technologies Inc. | 22.51 B CHF | 50.705 CHF | −4.04% | 41 | 0.81 | 15.19 | 3.34 CHF | −20.71% | 0.23% | Buy |
 ICYIncyte Corporation | 19.21 B CHF | 94.024 CHF | +1.70% | 20 | 0.16 | 16.64 | 5.65 CHF | +1,875.34% | 0.00% | Buy |
 22UABioNTech SE Sponsored ADRDR | 18.46 B CHF | 74.141 CHF | −1.14% | 26 | 1.07 | — | −4.69 CHF | −54.27% | 0.00% | Buy |
 0QFModerna, Inc. | 17.53 B CHF | 44.369 CHF | −5.15% | 107 | 1.00 | — | −6.51 CHF | +15.69% | 0.00% | Neutral |
| MRNA.USDModerna, Inc. | 17.53 B CHF | 47.200 USD | 0.00% | 7.9 K | 6.15 | — | −6.51 CHF | +6.61% | 0.00% | Neutral |
 VTRSViatris, Inc. | 16.53 B CHF | 13.800 CHF | +4.42% | 55 | 0.55 | — | −0.21 CHF | +92.64% | 2.78% | Buy |
 STMNStraumann Holding AG | 15.33 B CHF | 96.12 CHF | −0.50% | 158.12 K | 0.58 | 43.11 | 2.23 CHF | −8.00% | 1.04% | Buy |
| QS51Straumann Holding AG | 15.33 B CHF | 96.495 CHF | −0.71% | 133 | 1.02 | 43.28 | 2.23 CHF | −8.00% | 1.04% | Buy |
 ZIMZimmer Biomet Holdings, Inc. | 14.44 B CHF | 72.869 CHF | −0.16% | 7 | 0.07 | 23.68 | 3.08 CHF | −22.95% | 1.05% | Neutral |
 SRTSartorius AG | 12.68 B CHF | 163.185 CHF | −4.00% | 20 | 1.18 | 62.24 | 2.62 CHF | +86.04% | 0.42% | Buy |
 SOONSonova Holding AG | 12.16 B CHF | 211.4 CHF | +1.25% | 124.67 K | 0.94 | 29.27 | 7.22 CHF | −20.12% | 2.22% | Neutral |
| PHBNSonova Holding AG | 12.16 B CHF | 212.042 CHF | +2.28% | 1 | 0.00 | 29.36 | 7.22 CHF | −20.12% | 2.22% | Neutral |
 CBHDColoplast A/S Class B | 11.26 B CHF | 50.809 CHF | +9.70% | 500 | 4.38 | 44.12 | 1.15 CHF | −55.53% | 5.70% | Neutral |
 BM8BioMarin Pharmaceutical Inc. | 9.37 B CHF | 47.379 CHF | +9.65% | 10 | 0.01 | 43.26 | 1.10 CHF | −54.09% | 0.00% | Buy |
 BANBBachem Holding AG Class B | 5.63 B CHF | 73.104 CHF | −3.46% | 22 | 0.13 | 36.83 | 1.98 CHF | +23.77% | 1.20% | Buy |
| BANBBachem Holding AG Class B | 5.63 B CHF | 75.05 CHF | −0.33% | 104.32 K | 0.80 | 37.81 | 1.98 CHF | +23.77% | 1.20% | Buy |
 OWXYpsomed Holding AG | 5.21 B CHF | 381.441 CHF | −0.54% | 4 | 0.12 | 23.40 | 16.30 CHF | +154.29% | 0.58% | Buy |
| YPSNYpsomed Holding AG | 5.21 B CHF | 382.4 CHF | +0.31% | 8.12 K | 0.62 | 23.46 | 16.30 CHF | +154.29% | 0.58% | Buy |
 2CVConvaTec Group Plc | 4.58 B CHF | 2.371 CHF | −9.57% | 4.35 K | — | 34.15 | 0.07 CHF | −15.61% | 2.49% | Strong buy |
 1CGCRISPR Therapeutics AG | 3.67 B CHF | 38.932 CHF | −4.25% | 450 | 1.07 | — | −4.96 CHF | −24.18% | 0.00% | Buy |
 SFZNSiegfried Holding AG | 3.19 B CHF | 70.935 CHF | +0.52% | 5 | 0.01 | 18.42 | 3.85 CHF | +4.40% | 0.57% | Buy |
| SFZNSiegfried Holding AG | 3.19 B CHF | 70.70 CHF | −0.14% | 57.95 K | 0.93 | 18.36 | 3.85 CHF | +4.40% | 0.57% | Buy |
 FIEFielmann Group AG | 3.07 B CHF | 36.600 CHF | −1.86% | 100 | 0.68 | 16.20 | 2.26 CHF | +32.69% | 2.92% | Strong buy |
 EZP1COMET Holding AG | 2.77 B CHF | 362.831 CHF | +0.51% | 22 | 0.47 | 230.93 | 1.57 CHF | −65.24% | 0.14% | Buy |
| COTNCOMET Holding AG | 2.77 B CHF | 355.8 CHF | −0.89% | 17.42 K | 0.59 | 226.45 | 1.57 CHF | −65.24% | 0.14% | Buy |
 6MDMedacta Group SA | 2.6 B CHF | 130.460 CHF | +0.53% | 100 | 2.34 | 29.09 | 4.49 CHF | +28.69% | 0.84% | Buy |
| MOVEMedacta Group SA | 2.6 B CHF | 130.2 CHF | +0.77% | 24.05 K | 1.02 | 29.03 | 4.49 CHF | +28.69% | 0.84% | Buy |
 TENTecan Group AG | 2.34 B CHF | 180.113 CHF | +0.22% | 2 | 0.18 | — | −8.74 CHF | −265.10% | 1.65% | Buy |
| TECNTecan Group AG | 2.34 B CHF | 182.2 CHF | +1.50% | 43.08 K | 0.86 | — | −8.74 CHF | −265.10% | 1.65% | Buy |
 AFXCarl Zeiss Meditec AG | 2.31 B CHF | 28.700 CHF | +2.41% | 70 | 0.32 | 28.68 | 1.00 CHF | −41.01% | 1.98% | Neutral |
 IDIAIdorsia Ltd. | 1.62 B CHF | 6.165 CHF | +1.48% | 430.64 K | 0.38 | — | −0.95 CHF | +29.70% | 0.00% | Buy |
| 19TIdorsia Ltd. | 1.62 B CHF | 6.158 CHF | +2.07% | 198 | 0.09 | — | −0.95 CHF | +29.70% | 0.00% | Buy |
 DRW8Draegerwerk AG & Co. KGaA | 1.51 B CHF | 67.592 CHF | +25.09% | 52 | — | 8.96 | 7.54 CHF | +28.12% | 2.82% | Buy |
 8H0PolyPeptide Group AG | 1.44 B CHF | 41.765 CHF | −8.85% | 212 | 1.09 | — | −0.61 CHF | −7.03% | 0.00% | Buy |
| PPGNPolyPeptide Group AG | 1.44 B CHF | 43.75 CHF | −0.11% | 161.98 K | 0.74 | — | −0.61 CHF | −7.03% | 0.00% | Buy |
 SKANSKAN Group AG | 1.29 B CHF | 57.2 CHF | +1.78% | 6.61 K | 0.37 | 79.03 | 0.72 CHF | −58.06% | 0.38% | Strong buy |
 RXRXRecursion Pharmaceuticals, Inc. Class A | 1.28 B CHF | 2.500 CHF | +6.38% | 500 | 0.36 | — | −0.96 CHF | +38.93% | 0.00% | Buy |
 38IIntellia Therapeutics, Inc. | 1.22 B CHF | 9.231 CHF | −16.01% | 300 | 0.49 | — | −2.82 CHF | +38.99% | 0.00% | Buy |
 VIRVir Biotechnology, Inc. | 1.2 B CHF | 7.638 CHF | +0.16% | 250 | — | — | −2.51 CHF | +32.95% | 0.00% | Strong buy |
 1RUMedartis Holding AG | 1.18 B CHF | 92.135 CHF | +10.91% | 20 | 0.52 | 137.35 | 0.67 CHF | +150.58% | 0.00% | Strong buy |
| MEDMedartis Holding AG | 1.18 B CHF | 86.2 CHF | −0.23% | 1.77 K | 0.46 | 128.50 | 0.67 CHF | +150.58% | 0.00% | Strong buy |
 COPNCosmo Pharmaceuticals NV | 1.07 B CHF | 63.6 CHF | −7.69% | 75.84 K | 2.35 | — | −0.35 CHF | −111.27% | 3.04% | Strong buy |
 41XArdelyx, Inc. | 1.02 B CHF | 4.108 CHF | −20.63% | 250 | 0.15 | — | −0.19 CHF | +5.27% | 0.00% | Strong buy |
 YTSNKuros Biosciences Ltd. | 781.28 M CHF | 19.939 CHF | −3.83% | 22 | 0.10 | 433.46 | 0.05 CHF | — | 0.00% | Strong buy |
| KURNKuros Biosciences Ltd. | 781.28 M CHF | 19.80 CHF | −2.75% | 141.42 K | 1.25 | 430.43 | 0.05 CHF | — | 0.00% | Strong buy |
 BSLNBasilea Pharmaceutica AG | 646.31 M CHF | 52.6 CHF | +0.57% | 15.43 K | 0.60 | 17.42 | 3.02 CHF | −48.16% | 0.00% | Buy |
 MEDXmedmix AG | 337.94 M CHF | 8.19 CHF | +3.67% | 296.1 K | 2.14 | 40,950.00 | 0.00 CHF | — | 1.22% | Strong buy |